Private Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $8.58M | Sell |
258,550
-22,927
| -8% | -$811K | 2.01% | 16 |
|
|
2023
Q2 | $10.3M | Sell |
281,477
-54,817
| -16% | -$2.13M | 1.98% | 16 |
|
|
2023
Q1 | $13.7M | Sell |
336,294
-7,748
| -2% | -$335K | 2.26% | 16 |
|
|
2022
Q4 | $17.6M | Buy |
344,042
+9,406
| +3% | +$451K | 2.99% | 12 |
|
|
2022
Q3 | $14.6M | Sell |
334,636
-3,830
| -1% | -$186K | 2.59% | 14 |
|
|
2022
Q2 | $17.7M | Sell |
338,466
-3,885
| -1% | -$198K | 2.88% | 10 |
|
|
2022
Q1 | $17.7M | Sell |
342,351
-22,701
| -6% | -$1.18M | 2.4% | 12 |
|
|
2021
Q4 | $21.6M | Sell |
365,052
-4,127
| -1% | -$204K | 2.65% | 12 |
|
|
2021
Q3 | $15.9M | Sell |
369,179
-10,778
| -3% | -$477K | 2.16% | 13 |
|
|
2021
Q2 | $14.9M | Sell |
379,957
-4,567
| -1% | -$178K | 1.98% | 17 |
|
|
2021
Q1 | $13.9M | Sell |
384,524
-6,573
| -2% | -$233K | 1.95% | 17 |
|
|
2020
Q4 | $14.4M | Sell |
391,097
-36,401
| -9% | -$1.34M | 2.16% | 15 |
|
|
2020
Q3 | $14.9M | Sell |
427,498
-1,044
| -0.2% | -$36.6K | 2.48% | 11 |
|
|
2020
Q2 | $13.3M | Sell |
428,542
-1,161
| -0.3% | -$39.4K | 2.36% | 14 |
|
|
2020
Q1 | $13.3M | Buy |
429,703
+740
| +0.2% | +$25.2K | 2.8% | 11 |
|
|
2019
Q4 | $15.9M | Sell |
428,963
-6,721
| -2% | -$239K | 2.6% | 11 |
|
|
2019
Q3 | $14.9M | Sell |
435,684
-19,551
| -4% | -$711K | 2.57% | 12 |
|
|
2019
Q2 | $18.7M | Sell |
455,235
-3,962
| -0.9% | -$157K | 3.19% | 4 |
|
|
2019
Q1 | $18.5M | Sell |
459,197
-18,716
| -4% | -$750K | 3.29% | 4 |
|
|
2018
Q4 | $19.8M | Sell |
477,913
-26,266
| -5% | -$1.09M | 3.84% | 2 |
|
|
2018
Q3 | $21.1M | Sell |
504,179
-451
| -0.1% | -$17.4K | 3.32% | 4 |
|
|
2018
Q2 | $17.4M | Sell |
504,630
-4,867
| -1% | -$166K | 2.8% | 9 |
|
|
2018
Q1 | $17.2M | Sell |
509,497
-12,045
| -2% | -$414K | 2.93% | 6 |
|
|
2017
Q4 | $17.9M | Sell |
521,542
-6,883
| -1% | -$235K | 2.85% | 5 |
|
|
2017
Q3 | $17.9M | Sell |
528,425
-16,302
| -3% | -$524K | 2.88% | 5 |
|
|
2017
Q2 | $17.4M | Sell |
544,727
-30,424
| -5% | -$959K | 2.8% | 7 |
|
|
2017
Q1 | $18.7M | Buy |
575,151
+5,522
| +1% | +$174K | 3.04% | 5 |
|
|
2016
Q4 | $17.6M | Sell |
569,629
-7,390
| -1% | -$226K | 2.93% | 7 |
|
|
2016
Q3 | $18.5M | Sell |
577,019
-1,616
| -0.3% | -$54K | 3.11% | 4 |
|
|
2016
Q2 | $19.3M | Sell |
578,635
-17,356
| -3% | -$554K | 3.4% | 4 |
|
|
2016
Q1 | $16.8M | Buy |
595,991
+1,400
| +0.2% | +$40K | 3.04% | 4 |
|
|
2015
Q4 | $18.2M | Sell |
594,591
-1,410
| -0.2% | -$44.4K | 3.3% | 4 |
|
|
2015
Q3 | $17.8M | Buy |
596,001
+3,592
| +0.6% | +$115K | 3.32% | 3 |
|
|
2015
Q2 | $18.8M | Sell |
592,409
-686
| -0.1% | -$22.4K | 3.17% | 5 |
|
|
2015
Q1 | $19.6M | Sell |
593,095
-3,403
| -0.6% | -$108K | 3.19% | 5 |
|
|
2014
Q4 | $17.6M | Sell |
596,498
-1,901
| -0.3% | -$54.5K | 2.8% | 6 |
|
|
2014
Q3 | $16.8M | Buy |
598,399
+30,817
| +5% | +$865K | 2.69% | 7 |
|
|
2014
Q2 | $16M | Buy |
567,582
+22,115
| +4% | +$630K | 2.57% | 6 |
|
|
2014
Q1 | $16.6M | Buy |
545,467
+24,699
| +5% | +$736K | 2.8% | 6 |
|
|
2013
Q4 | $15.1M | Buy |
520,768
+17,032
| +3% | +$496K | 2.61% | 7 |
|
|
2013
Q3 | $13.7M | Sell |
503,736
-27,234
| -5% | -$741K | 2.63% | 6 |
|
|
2013
Q2 | $14.1M | Buy |
+530,970
| New | +$14.7M | 2.69% | 6 |
|
Other funds holding PFE
Private Asset Management's PFE Position: Q3 2023 in Review
Private Asset Management reduced its Pfizer (PFE) stake by 8.1% in Q3 2023, selling an estimated $811K and leaving 258,550 shares worth $8.58M. The position accounts for 2.01% of the portfolio, ranked #16.
Private Asset Management first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $21.6M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Private Asset Management held 258,550 shares of Pfizer worth $8.58M as of Q3 2023.
- Private Asset Management sold 22,927 Pfizer shares in Q3 2023, an estimated $811K.
- Pfizer made up 2.01% of Private Asset Management's portfolio in Q3 2023, its #16 holding.
- Private Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
- Private Asset Management's Pfizer position peaked at $21.6M in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Private Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.